RITTER PHARMACEUTICALS INC Business Operations Contracts & Agreements
22 Contracts & Agreements
- Advisory Agreements (1 contract)
- Agency Agreements (10)
- Cooperation Agreements (1)
- Development Agreements (1)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Services Agreements (1)
- Settlement Agreements (1)
- Supply Agreements (2)
- Termination Agreements (2)
- Form of Placement Agency Agreement (Filed With SEC on October 24, 2024)
- Form of Placement Agency Agreement (Filed With SEC on August 22, 2024)
- Form of Placement Agency Agreement (Filed With SEC on August 9, 2024)
- Form of Placement Agency Agreement (Filed With SEC on August 7, 2024)
- Termination Agreement dated as of March 16, 2024 between the Company and Pan-RAS Holdings, Inc (Filed With SEC on March 28, 2024)
- Amendment and Settlement Agreement, dated July 20, 2023, by and between Qualigen Therapeutics, Inc. and Nanosynex Ltd (Filed With SEC on July 26, 2023)
- Placement Agency Agreement between Qualigen Therapeutics, Inc. and A.G.P./Alliance Global Partners, dated November 29, 2021 (Filed With SEC on December 1, 2021)
- Letter dated June 22, 2021 to A.G.P./Alliance Global Partners giving notice of termination of Sales Agreement (Filed With SEC on August 16, 2021)
- Amendment to Distribution and Development Agreement between Sekisui Diagnostics, LLC and Qualigen, Inc., dated as of July 1, 2021 [signed August 2, 2021] (Filed With SEC on August 13, 2021)
- Placement Agency Agreement between Qualigen Therapeutics, Inc. and A.G.P./Alliance Global Partners, dated December 15, 2020 (Filed With SEC on December 18, 2020)
- Letter agreement amending M&A Advisory Agreement between the Company and A.G.P./Alliance Global Partners dated May 20, 2020 (Filed With SEC on August 14, 2020)
- Placement Agency Agreement between Qualigen Therapeutics, Inc. and A.G.P./Alliance Global Partners, dated August 2, 2020 (Filed With SEC on August 4, 2020)
- Placement Agency Agreement between the Company and A.G.P./Alliance Global Partners, dated July 8, 2020 (Filed With SEC on July 9, 2020)
- Form of Indemnification Agreement - Qualigen, Inc (Filed With SEC on May 29, 2020)
- Sales Agreement dated November 6, 2019 between the Registrant and A.G.P./Alliance Global Partners (Filed With SEC on November 7, 2019)
- Placement Agency Agreement, by and between Ritter Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners, dated October 30, 2018 (Filed With SEC on November 9, 2018)
- Amended and Restated Master Services Agreement, dated May 1, 2018, by and between Ritter Pharmaceuticals, Inc. and Medpace , Inc (Filed With SEC on May 7, 2018)
- Warrant Agency Agreement, dated September 29, 2017 by and between Ritter Pharmaceuticals, Inc. and Corporate Stock Transfer, Inc. (including the form of warrant certificate) (Filed With SEC on October 4, 2017)
- AMENDMENT No. 2 TO CLINICAL SUPPLY AND COOPERATION AGREEMENT (Filed With SEC on November 10, 2015)
- AMENDMENT 1 To the Clinical Supply and Cooperation Agreement(hereinafter “CSCA”) entered into between: (Filed With SEC on April 24, 2015)
- Clinical Supply and Cooperation Agreement BetweenRitter & RSM/Inalco CLINICAL SUPPLY AND COOPERATION AGREEMENT (also referred to as “CSCA”) BETWEEN (Filed With SEC on April 24, 2015)
- RITTER PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on April 24, 2015)
